drugset / Trial / NCT03996434
Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS
Phase 4
Completed
300 enrolled
ClinAmygate
Al-Azhar University · collabBeni-Suef University · collabCairo University · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The aim of this work is to study the value of GnRH antagonist subcutaneous administration as an alternative to coasting in prevention of severe OHSS and its impact on embryos quality \& the outcome of ICSI.
Timeline
- Start
- 2019-07-01
- Primary completion
- 2019-11-10
- Completion
- 2019-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetrorelix | Other / unclassified | 0.25 mg | Subcutaneous |